These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9224413)

  • 1. Pravastatin increases survival and inhibits natural killer cell enhancement factor in liver transplanted rats.
    Kakkis JL; Ke B; Dawson S; Maggard M; Si M; Kaldas F; Cai W; Shau H; Seu P; Sauri H; Busuttil RW; Imagawa DK
    J Surg Res; 1997 May; 69(2):393-8. PubMed ID: 9224413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
    Arita S; Kasraie A; Une S; Ohtsuka S; Smith CV; Mullen Y
    Cell Transplant; 2001; 10(7):639-44. PubMed ID: 11714199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pravastatin prolongs graft survival in an allogeneic rat model of orthotopic single lung transplantation.
    Li Y; Köster T; Mörike C; v Hörsten S; Martin U; Bader M; Haverich A; Simon AR
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):515-24. PubMed ID: 16860567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
    Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
    J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rat model of chronic allograft liver rejection.
    Gao LH; Zheng SS; Zhu YF; Wan YL; Wei GQ; Qian SK; Jiang WJ
    Transplant Proc; 2005 Jun; 37(5):2327-32. PubMed ID: 15964409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant blood transfusion and cyclosporin A induce long-term hamster cardiac xenograft survival in immunocompetent rats.
    Vriens PW; Stoot JH; van der Steenhoven TJ; Hoyt G; Bouwman E; Robbins RC
    Xenotransplantation; 2005 Jan; 12(1):63-71. PubMed ID: 15598275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased efficacy of CSA following rearterialization in the rat OLTX model.
    Freise CE; Liu T; Osorio RW; Ferrell L; Ascher NL; Roberts JP
    J Surg Res; 1995 Oct; 59(4):493-6. PubMed ID: 7564323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antioxidant properties of natural killer-enhancing factor-B and induction of its expression by hydrogen peroxide.
    Kim AT; Sarafian TA; Shau H
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):135-42. PubMed ID: 9356316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
    Kobashigawa JA; Moriguchi JD; Laks H; Wener L; Hage A; Hamilton MA; Cogert G; Marquez A; Vassilakis ME; Patel J; Yeatman L
    J Heart Lung Transplant; 2005 Nov; 24(11):1736-40. PubMed ID: 16297773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
    Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
    Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated response in rat liver chronic rejection.
    Wan R; Ying W; Zeng L; Deng X; Chen H; Gao L
    Transplant Proc; 2011 Jun; 43(5):1976-9. PubMed ID: 21693310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.
    Imagawa DK; Dawson S; Holt CD; Kirk PS; Kaldas FM; Shackleton CR; Seu P; Rudich SM; Kinkhabwala MM; Martin P; Goldstein LI; Murray NG; Terasaki PI; Busuttil RW
    Transplantation; 1996 Oct; 62(7):934-42. PubMed ID: 8878387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.